Content area

Abstract

ABSTRACT

Introduction

L‐Quebrachitol (LQB), a naturally occurring bioactive compound, exhibits anti‐inflammatory, anti‐oxidant, anti‐cancer, and anti‐diabetic properties. However, its therapeutic potential in convulsant management remains largely unexplored. The objective of this study was to investigate the anticonvulsant effects of LQB in an In Vivo model and to examine its molecular interactions via In Silico docking simulations.

Methods

In the In Vivo study, pentylenetetrazol (PTZ) was administered intraperitoneally (i.p.) at 80 mg/kg to induce convulsions, and the test animals were treated orally with three doses of LQB (1, 5, and 10 mg/kg), with carbamazepine (CBZ) at 80 mg/kg as a standard drug.

Results

The results indicated that LQB at all tested doses significantly (p < 0.05) prolonged seizure latency and decreased convulsion frequency, with the 10 mg/kg dose showing the most significant effects. Furthermore, the combination of LQB (10 mg/kg) and CBZ (80 mg/kg) resulted in a synergistic increase in anticonvulsant activity. In the In Silico study, molecular docking analysis revealed that both LQB and CBZ interacted with the voltage‐gated sodium channel (VGSC), a key receptor involved in convulsions, with LQB demonstrating a binding affinity (BA) of −5.4 kcal/mol, which was moderate compared to CBZ's BA.

Conclusion

LQB showed potential anti‐convulsant activity in PTZ‐induced convulsion animals, possibly through blocking sodium channel receptors. Further studies are needed to clarify its mechanisms and clinical potential in convulsion treatment.

Details

1009240
Location
Title
L‐quebrachitol Modulates the Anti‐convulsant Effects of Carbamazepine Possibly Through Voltage‐gated Sodium Channel Blocking Mechanism in Chicks: In Vivo and In Silico Studies
Author
Asrafi, Asifa 1 ; Aslam, Mohammad 1 ; Alkhathami, Ali G. 2 ; Hossain, Md. Sakib 3 ; Rakib, Imam Hossen 4 ; Al Hasan, Md. Sakib 4   VIAFID ORCID Logo  ; Nun, Feroz Khan 3 ; Amin, Md. Faisal 5 ; Islam, Muhammad Torequl 6   VIAFID ORCID Logo 

 Department of Biochemistry and Molecular Biology, Gopalganj Science and Technology University, Gopalganj, Bangladesh 
 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia 
 Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh 
 Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh, Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh 
 School of Integrative Biological and Chemical Sciences, The University of Texas Rio Grande Valley, Texas, USA 
 Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh, Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh, Pharmacy Discipline, Khulna University, Khulna, Bangladesh 
Publication title
Brain and Behavior; Los Angeles
Volume
15
Issue
7
Number of pages
11
Publication year
2025
Publication date
Jul 1, 2025
Section
ORIGINAL ARTICLE
Publisher
John Wiley & Sons, Inc.
Place of publication
Los Angeles
Country of publication
United States
Publication subject
e-ISSN
21623279
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2025-07-07
Milestone dates
2025-05-20 (manuscriptRevised); 2025-07-07 (publishedOnlineFinalForm); 2025-04-17 (manuscriptReceived); 2025-06-15 (manuscriptAccepted)
Publication history
 
 
   First posting date
07 Jul 2025
ProQuest document ID
3233904571
Document URL
https://www.proquest.com/scholarly-journals/l-quebrachitol-modulates-anti-convulsant-effects/docview/3233904571/se-2?accountid=208611
Copyright
© 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-12-10
Database
ProQuest One Academic